Literature DB >> 33716834

Evolving Concepts of the Schizophrenia Spectrum: A Research Domain Criteria Perspective.

Bruce N Cuthbert1, Sarah E Morris1.   

Abstract

Several trends intersecting over the past two decades have generated increasing debate as to how the concepts of schizophrenia, the schizophrenia spectrum, and the psychotic disorders spectrum should be regarded. These trends are reflected in various areas of research such as genomics, neuroimaging, and data-driven computational studies of multiple response systems. Growing evidence suggests that schizophrenia represents a broad and heterogenous syndrome, rather than a specific disease entity, that is part of a multi-faceted psychosis spectrum. Progress in explicating these various developments has been hampered by the dependence upon sets of symptoms and signs for determining a diagnosis, and by the reliance on traditional diagnostic categories in reviewing clinical research grants. To address these concerns, the U.S. National Institute of Mental Health initiated the Research Domain Criteria (RDoC) project, a translational research program that calls for studies designed in terms of empirically-based functions (such as cognitive control or reward learning) rather than diagnostic groups. RDoC is a research framework rather than an alternative diagnostic system, intended to provide data that can inform future nosological manuals. This commentary includes a brief summary of RDoC as it pertains to schizophrenia and psychotic spectra, examples of recent data that highlight the utility of the approach, and conclusions regarding the implications for evolving conceptualizations of serious mental illness.
Copyright © 2021 Cuthbert and Morris.

Entities:  

Keywords:  psychiatric diagnosis; psychiatric nosology; psychopathology; psychosis spectrum; research domain criteria; schizophrenia spectrum

Year:  2021        PMID: 33716834      PMCID: PMC7947312          DOI: 10.3389/fpsyt.2021.641319

Source DB:  PubMed          Journal:  Front Psychiatry        ISSN: 1664-0640            Impact factor:   4.157


  34 in total

1.  Extended psychosis phenotype--yes: single continuum--unlikely.

Authors:  N Kaymaz; J van Os
Journal:  Psychol Med       Date:  2010-03-18       Impact factor: 7.723

2.  The environment and schizophrenia.

Authors:  Jim van Os; Gunter Kenis; Bart P F Rutten
Journal:  Nature       Date:  2010-11-11       Impact factor: 49.962

3.  The NIMH Research Domain Criteria Initiative: Background, Issues, and Pragmatics.

Authors:  Michael J Kozak; Bruce N Cuthbert
Journal:  Psychophysiology       Date:  2016-03       Impact factor: 4.016

4.  "Schizophrenia" does not exist.

Authors:  Jim van Os
Journal:  BMJ       Date:  2016-02-02

5.  The evidence-based group-level symptom-reduction model as the organizing principle for mental health care: time for change?

Authors:  Jim van Os; Sinan Guloksuz; Thomas Willem Vijn; Anton Hafkenscheid; Philippe Delespaul
Journal:  World Psychiatry       Date:  2019-02       Impact factor: 49.548

6.  Schizophrenia and the neurodevelopmental continuum:evidence from genomics.

Authors:  Michael J Owen; Michael C O'Donovan
Journal:  World Psychiatry       Date:  2017-10       Impact factor: 49.548

7.  Clusters, Dimensions, and Hierarchies: Finding a Path Forward for the Neuroscience of Mental Disorders?

Authors:  Cameron S Carter
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2017-11-24

8.  Mapping the Heterogeneous Phenotype of Schizophrenia and Bipolar Disorder Using Normative Models.

Authors:  Thomas Wolfers; Nhat Trung Doan; Tobias Kaufmann; Dag Alnæs; Torgeir Moberget; Ingrid Agartz; Jan K Buitelaar; Torill Ueland; Ingrid Melle; Barbara Franke; Ole A Andreassen; Christian F Beckmann; Lars T Westlye; Andre F Marquand
Journal:  JAMA Psychiatry       Date:  2018-11-01       Impact factor: 21.596

9.  Examination of the Neural Basis of Psychoticlike Experiences in Adolescence During Reward Processing.

Authors:  Evangelos Papanastasiou; Elias Mouchlianitis; Dan W Joyce; Philip McGuire; Tobias Banaschewski; Arun L W Bokde; Uli Bromberg; Christian Büchel; Erin Burke Quinlan; Sylvane Desrivières; Herta Flor; Vincent Frouin; Hugh Garavan; Philip Spechler; Penny Gowland; Andreas Heinz; Bernd Ittermann; Jean-Luc Martinot; Marie-Laure Paillère Martinot; Eric Artiges; Frauke Nees; Dimitri Papadopoulos Orfanos; Luise Poustka; Sabina Millenet; Juliane H Fröhner; Michael N Smolka; Henrik Walter; Robert Whelan; Gunter Schumann; Sukhwinder Shergill
Journal:  JAMA Psychiatry       Date:  2018-10-01       Impact factor: 21.596

10.  Transdiagnostic approaches to mental health problems: Current status and future directions.

Authors:  Tim Dalgleish; Melissa Black; David Johnston; Anna Bevan
Journal:  J Consult Clin Psychol       Date:  2020-03
View more
  4 in total

1.  European Psychiatric Association guidance on assessment of cognitive impairment in schizophrenia.

Authors:  Antonio Vita; Wolfgang Gaebel; Armida Mucci; Gabriele Sachs; Andreas Erfurth; Stefano Barlati; Federico Zanca; Giulia Maria Giordano; Louise Birkedal Glenthøj; Merete Nordentoft; Silvana Galderisi
Journal:  Eur Psychiatry       Date:  2022-09-05       Impact factor: 7.156

2.  Tracing Links Between Early Auditory Information Processing and Negative Symptoms in Schizophrenia: An ERP Study.

Authors:  Giulia M Giordano; Francesco Brando; Andrea Perrottelli; Giorgio Di Lorenzo; Alberto Siracusano; Luigi Giuliani; Pasquale Pezzella; Mario Altamura; Antonello Bellomo; Giammarco Cascino; Antonio Del Casale; Palmiero Monteleone; Maurizio Pompili; Silvana Galderisi; Mario Maj
Journal:  Front Psychiatry       Date:  2021-12-20       Impact factor: 4.157

3.  Development of a Mobile Assessment Tool for Understanding Social Comparison Processes Among Individuals With Schizophrenia: Two-Phase Survey Study.

Authors:  Danielle Arigo; John Torous
Journal:  JMIR Form Res       Date:  2022-05-02

4.  Schizophrenia: A Narrative Review of Etiopathogenetic, Diagnostic and Treatment Aspects.

Authors:  Laura Orsolini; Simone Pompili; Umberto Volpe
Journal:  J Clin Med       Date:  2022-08-27       Impact factor: 4.964

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.